Publications

  1. Beh SC, Frohman EM. WEBINO and the Return of the King’s Speech. J Neurol Sci 2012;315(1-2):153-155
  2. Beh SC, Vernino S, Warnack WR. Clinical Reasoning: A 41-year-old comatose man with absent brainstem reflexes. Neurology 2012;78(7):e42-5 (with accompanying AAN podcast)
  3. Beh SC, Nations S, Pascual J, Vernino S. Ataxia and weakness in a young woman. Arch Neurol 2012;69(7):924-927
  4. Frohman AR, Schnurman Z, Conger A, Conger D, Beh S, Greenberg B, Sutter E, Calabresi PA, Balcer LJ, Frohman TC, Frohman EM. Multifocal Visual Evoked Potentials Are Influenced by Variable Contrast Stimulation in MS. Neurology 2012;79(8):797-801
  5. Blazek P, Davis SL, Greenberg BM, Conger A, Conger D, Vernino S, Beh S, Stuve O, Saidha S, Ratchford JN, Frohman T, Calabresi PA, Balcer LJ, and Frohman EM. Objective Characterization of the Relative Afferent Pupillary Defect in MS. J Neurol Sci 2012;323(1-2):193-200
  6. Beh SC, Greenberg BM, Frohman TC, Frohman EM. Transverse myelitis. Neurol Clin 2013;31:79-138
  7. Frohman TC, Davis SL, Beh S, Greenberg BM, Remington G, Frohman EM. Uhthoff’s phenomena in MS – clinical features and pathophysiology. Nat Rev Neurol 2013;9:535-540
  8. Frohman TC, Beh SC, Saidha S, Schnurman Z, Conger D, Conger A, Ratchford JN, Lopez C, Galetta SL, Calabresi PA, Balcer LJ, Green AJ, Frohman EM. Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology 2013;81:1-7
  9. Beh SC, Frohman TC, Frohman EM. Isolated mammillary body involvement on MRI in Wernicke’s encephalopathy. J Neurol Sci 2013;334:172-175
  10. Beh SC, Frohman EM. The menagerie of neurology: animal signs and the refinement of clinical acumen. Neurol Clin Pract 2014;4:e1-e9
  11. Beh SC, Tehrani AS, Kheradmand A, Zee DS. Damping of monocular pendular nystagmus with vibration in a patient with multiple sclerosis. Neurology 2014;82:1380-1381
  12. Schnurman Z, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, Frohman EM. Retinal architecture and mfERG optic nerve head component response characteristics in MS. Neurology 2014;82:1888-1896
  13. Beh SC, Muthusamy B, Calabresi PA, Hart J, Zee D, Patel V, Frohman EM. Hiding in plain sight: shining a spotlight on posterior cortical atrophy. Pract Neurol 2015;15(1):5-13
  14. Qureshi SS, Beh SC, Frohman TC, Frohman EM. An Update On Neuro-ophthalmology Of Multiple Sclerosis (MS): The Visual System As A Model To Study MS. Current Opinion in Neurology 2014;27:300-308
  15. Beh SC, Frohman TC, Frohman EM. Neuro-ophthalmic manifestations of cerebellar disease. 2014;32:1009-80
  16. Clough M, Millist L, Lizak N, Beh S, Frohman TC, Frohman EM, White O, Fielding J. Ocular motor measures of cognitive dysfunction in multiple sclerosis I: Inhibitory control. J Neurol 2015;262:1130-1137
  17. Clough M, Millist L, Lizak N, Beh S, Frohman TC, Frohman EM, White O, Fielding J. Ocular motor measures of cognitive dysfunction in multiple sclerosis II: Working memory. J Neurol 2015;262:1138-1147
  18. Beh SC, Frohman TC, Conger A, Conger D, Sutter EE, Frohman EM. Chapter 8: Electrophysiology of the Optic Nerve Head. In: Optical Coherence Tomography in Neurological Disease. 1st ed. Cambridge University Press, Cambridge; 2015
  19. Beh SC, Balcer LJ. Chapter 6: OCT and Low-Contrast Acuity. In: Optical Coherence Tomography in Neurological Disease. 1st ed. Cambridge University Press, Cambridge; 2015
  20. Beh SC, Frohman TC, Frohman EM. Neuro-ophthalmic manifestations of multiple sclerosis. In: Primer on Multiple Sclerosis. 2nd ed. Oxford University Press, New York; 2015
  21. Frohman A, Okuda D, Scott D, Beh S, Treadaway K, Mooi C, Shah A, Frohman T, Frohman E. Aquatic Training in MS: Neurotherapeutic Impact on Quality of Life. Ann Clin Transl Neurol 2015;2:864-872
  22. Beh SC. Review of Eye Movement Disorders in Clinical Practice. JAMA Neurol 2015;72:1380
  23. Fielding J, Clough M, Beh S, Millist L, Sears D, Frohman AN, Lizak N, Lim J, Kolbe S, Rennaker RL 2nd, Frohman TC, White OB, Frohman EM. Ocular motor signatures of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 2015;11:637-645
  24. Nolan R, Narayana K, Beh SC, Balcer LJ, Galetta SL. The utility of optical coherence tomography in the evaluation of monocular visual loss related to retinal ischemia. J Clin Neurosci 2016;26:116-121
  25. Beh SC, Frohman TC, Frohman EM. Monitoring Treatment in Multiple Sclerosis. In: Optical Coherence Tomography in Multiple Sclerosis – Clinical Applications. 1st ed. Springer International Publishing; 2016
  26. Zhovtis Ryerson L, Frohman TC, Foley J, Kister I, Weinstock-Guttman B, Tornatore G, Pandey K, Donnelly S, Pawate S, Bomprezzi R, Smith D, Kolb C, Qureshi S, Okuda D, Kalina J, Rimler Z, Green R, Monson N, Hoyt T, Bradshaw M, Fallon J, Chamot E, Bucello M, Beh S, Cutter G, Major E, Herbert J, Frohman EM. Extended interval dosing of natalizumab in multiple sclerosis. J Neurol Neurosurg Psychiatry 2016;87:885-889
  27. Frohman TC, Beh SC, Kildebeck EJ, Narayan R, Treadaway K, Greenberg B, Frohman EM. Neurotherapeutic strategies for multiple sclerosis. Neurol Clin 2016;34:483-523
  28. Kildebeck EJ, Narayan R, Nath A, Weiner H, Beh S, Calabresi PA, Steinman L, Major EO, Frohman TC, Frohman EM. The emergence of neuroepidemiology, neurovirology, and neuroimmunology: the legacies of John F. Kurtzke and Richard ‘Dick’ T. Johnson. J Neurol 2017;264:817-828
  29. Beh SC, Frohman TC, Frohman EM. Neuromyelitis Optica: Immunopathogenesis, Clinical Manifestations, and Treatments. Invited review for: Inflammatory Disorders of the Nervous System: pathogenesis, immunology, and clinical management. Springer International Publishing; 2017
  30. Beh SC, Kildebeck E, Narayan R, Desena A, Schnell D, Rowe ES, Rowe V, Burns D, Whitworth L, Frohman TC, Greenberg B, Frohman EM. High-dose methotrexate with leucovorin rescue: for monumentally severe CNS inflammatory syndromes. J Neurol Sci 2017;372:187-195
  31. Beh SC, Frohman TC, Frohman EM. Cerebellar control of eye movements. J Neuroophthalmology 2017;37:87-98 (with accompanying podcast)
  32. Meltzer E, Sguigna PV, Subei A, Beh S, Kildebeck E, Conger D, Conger A, Lucero M, Frohman BS, Frohman AN, Saidha S, Galetta S, Calabresi PA, Rennaker R, Frohman TC, Kardon RH, Balcer LJ, Frohman EM. Retinal architecture and melanopsin-mediated pupillary response characteristics: a putative pathophysiologic signature for the retino-hypothalamic tract in multiple sclerosis. JAMA Neurology 2017;74:574-582
  33. Beh SC. Temporal Evolution of the Trident and Piglet Signs of Osmotic Demyelination Syndrome. J Neurol Sci 2017;373:268-273
  34. Al-Louzi O, Sotirchos ES, Vidal-Jordana A, Beh SC, Button J, Ying HS, Balcer EM, Saidha S, Calabresi PA, Newsome SD. Characteristics of morphologic macular abnormalities in neuroimmunology practice. Mult Scler 2017;1352458517741206
  35. Beh SC. Top 5 CNS causes of dizziness. Published Oct 25, 2017 in the Neurology Times (http://www.neurologytimes.com/headache-and-migraine/top-5-cns-causes-dizziness)
  36. Beh SC. A case of vestibular migraine resolving on warfarin and topiramate. Headache 2018;58:599-600
  37. Beh SC. Horizontal direction-changing positional nystagmus and vertigo: a case of vestibular migraine masquerading as horizontal canal BPPV. Headache 2018;58:1113-1117
  38. Beh SC. Vestibular migraine: diagnostic criteria and evaluation. Published Dec 11, 2018 in the Neurology Times (https://www.neurologytimes.com/headache-and-migraine/vestibular-migraine-diagnostic-criteria-and-evaluation)
  39. Beh SC. Tourniquet-induced sciatic nerve injury: an unusual complication of coronary artery bypass graft surgery. Neurol Neurosci Res 2018;2(1):1
  40. Beh SC. Drug-related polyarthralgias with levodopa-carbidopa. Neurol Neurosci Res 2019;2(1):2
  41. Beh SC. Thrown around by the devil. Published March 25, 2019 in the Neurology Times (https://www.neurologytimes.com/nervous-system-diseases/thrown-around-devil)
  42. Beh SC, Masrour S, Smith SV, Friedman DI. Clinical characteristics of Alice in Wonderland syndrome in a cohort with vestibular migraine. Neurol Clin Pract 2018;8:389-396
  43. Beh SC, Masrour S, Smith SV, Friedman DI. The spectrum of vestibular migraine: clinical features, examination, and triggers. Headache 2019;59:727-740
  44. Beh SC. “Eye of the Tiger” in a patient with multiple sclerosis.  J Neurol Sci 2019;399:1-2
  45. Conger D, Beh SC. Seeing function in structure: “incidental” eye findings on OCT in a patient with multiple sclerosis. Mult Scler Relat Disord 2019;31:72-73
  46. Beh SC. Vestibular migraine: a primer. Published November 8, 2019 in Medscape (https://www.medscape.com/viewarticle/920797)
  47. Beh SC, Friedman DI. Acute vestibular migraine treatment with non-invasive vagus nerve stimulation. Neurology 2019;93:e1715-e1719.
  48. Beh SC. Vestibular migraine: how to sort it out and what to do about it. J Neuroophthalmol 2019;39:208-219
  49. Beh SC. External trigeminal nerve stimulation: potential rescue treatment for acute vestibular migraine. Journal of the Neurological Sciences 2020;408:116550
  50. Beh SC. Non-invasive vagus nerve stimulation for nausea prevention during BPPV treatment. Neuromodulation 2020 [Epub ahead of print]

Presentations

  1. Beh SC, Vernino S. The Atrophic Hands. Presented at the 33rd Annual Carrell-Krusen Neuromuscular Symposium in 2011.
  2. Beh SC, Frohman EM. WEBINO and re-emergent developmental stuttering: a case report. Presented at the Gordon Research Conference on Eye Movements, 2011.
  3. Beh SC, Karunapuzha C, Chitnis S. Co-existing HTT and ATXN8OS repeat expansions and a ‘face of the giant panda’ sign on MRI in a patient with a complex movement disorder. Presented at the American Neurological Association (ANA) 136th Annual Meeting, 2011.
  4. Beh SC, Schnurman Z, Frohman TC, Conger A, Conger D, Sutter E, Balcer L, Calabresi P, Frohman EM. The Optic Nerve Head Component: A Novel Electrophysiologic Marker of Optic Neuropathy in MS and Neuromyelitis Optica. Platform (S48.001) presentation at the 64th AAN Annual Meeting 2012.
  5. Conger A, Conger D, Frohman T, Beh S, Greenberg B, Balcer L, Calabresi P, Frohman EM.  Assessment of multiple sclerosis patients with a known history of unilateral optic neuritis shows optic nerve head component loss in fellow unaffected eye. Platform (S58.004) presentation at the 64th AAN Annual Meeting 2012.
  6. Frohman T, Schnurman Z, Beh S, Sutter E, Conger A, Conger D, Saidha S, Calabresi P, Balcer L, Frohman EM. The optic nerve head component of the multifocal electroretinogram: a novel metric for dissecting pathophysiologic mechanisms in MS. Platform (S10.001) presentation at the 64th AAN Annual Meeting 2012.
  7. Conger D, Conger A, Frohman T, Balcer L, Calabresi P, Beh S, Greenberg B, Frohman EM. Deriving clinically useful visual evoked potential measurements from 120 sector multifocal visual evoked potential sequences. Poster (P07.259) presentation at the 64th AAN Annual Meeting 2012.
  8. Graves DC, Frohman TC, Schurmann Z, Conger D, Conger A, Beh SC, Greenberg B, Saidha S, Ratchford J, Galetta SL, Calabresi PA, Green AJ, Balcer LJ, Frohman EM. The optic nerve head component of the multifocal electroretinogram: a novel signature for dissecting pathophysiologic mechanisms in MS. Presented at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Medical Congress 2012.
  9. Frohman TC, Schnurmann Z, Beh S, Conger A, Conger D, Calabresi P, Balcer L, Green A, Frohman EM. Optic Nerve Head Component of the Multifocal Electroretinogram in MS Optic Neuropathy: A Pathophysiologic Signature of Translaminar Demyelination. Poster (P05.174) presentation at the 65th AAN Annual Meeting 2013.
  10. Beh SC, Conger D, Conger A, Frohman TC, Green A, Calabresi PA, L Balcer LJ, Frohman EM. The Optic Nerve Head Component Waveform: “Eye-ing” Disease Activity in MS-related Optic Neuropathy. Presented at the Keystone Symposia Multiple Sclerosis Conference 2013.
  11. Beh SC, Frohman EM. A Tour through the Zoo of Neurology: Animal Eponyms and the Refinement of Clinical Acumen. Poster (P05.263) presentation at the AAN 2013 Annual Conference.
  12. Conger D, Conger A, Beh S, Frohman T, Frohman E. Comparison of two different visually evoked potential tests in a group of multiple sclerosis patients and controls: 2 repetitions per second and the m-sequence. Presented at the ECTRIMS Medical Congress 2013.
  13. Conger A, Conger D, Meltzer E, Sguigna P, Beh S, Frohman T, Frohman EM. Assessing functional damage of the retinal ganglion cell layer in patients with multiple sclerosis using two novel methods: photopic negative responses in electroretinography and multi-chromatic infrared pupillometry. Presented at the ECTRIMS Medical Congress 2013.
  14. Sguigna P, Meltzer E, Lucero M, Lucero M, Conger D, Conger A, Stokes V, Green A, Beh S, Rennaker R, Balcer L, Calabresi PA, Frohman TC, Kardon R, Frohman EM. The melanopsin mediated pupillary light reflex as a surrogate signature biomarker for the retinohypothalamic tract in MS. Presented at the ECTRIMS Medical Congress 2013.
  15. Beh SC, Kheradmand A, Frohman TC, Conger A, Conger D, Calabresi P, Balcer L, Frohman EF, Zee DS. Damping of Monocular Pendular Nystagmus with Vibration. Presented at the 2014 Annual Meeting of the North American Neuro-Ophthalmology Society (NANOS).
  16. Conger D, Lucero M, Lucero M, Conger A, Beh SC, Frohman B, Balcer L, Calabresi PA, Frohman EM, Frohman TC. Comparing the classic 2 repetitions per second (2 RPS) visually evoked potential with a new metric using the standard 60-second arc check size driven by a binary m-sequence in a group of multiple sclerosis patients and controls. Presented at the 2014 NANOS Annual Meeting.
  17. Beh SC, Frohman TC, Conger A, Conger D, Calabresi P, Balcer L, Zee DS, Frohman EM. NAIL-ing the Diagnosis: Real Neurologists Pay Attention to the Nails. Poster (P1.030) presentation at the AAN 2014 Annual Conference.
  18. Beh SC, Frohman TC, Conger A, Conger D, Calabresi P, Balcer L, Zee DS, Frohman EM. Food for Thought: A Serving of Food-Inspired Eponyms in Neurologic Practice. Poster (P1.296) presentation at the AAN 2014 Annual Conference.
  19. Herbert J, Ryerson LZ, Tornatore C, Foley J, Weinstock-Guttman B, Kister I, Padney K, Remington G, Frohman T, Major E, Qureshi S, Beh S, Okuda D, Utomo P, Kolb C, Hojnacki D, Frohman E. Multicenter retrospective study of extended dosing of natalizumab in multiple sclerosis: a strategy for mitigating risk of progressive multifocal leukoencephlopathy while maintaining efficacy? Poster (P2.251) presentation at the AAN 2014 Annual Conference.
  20. Beh SC, Kheradmand A, Frohman TC, Conger A, Conger D, Calabresi P, Balcer L, Frohman EF, Zee DS. Good Vibrations: A Novel Method of Damping Acquired Pendular Nystagmus with Vibration. Platform presentation (S19.001) at the AAN 2014 Annual Conference.
  21. Ryerson LZ, Herbert J, Tornatore C, Foley J, Weinstock-Guttman B, Kister I, Pandey K, Hojnacki D, Remington G, Frohman TC, Major E, Douek D, Qureshi S, Beh S, Okuda D, Utomo P, Rimler Z, Park J, Yoo S, Hoyt T, Chamot E, Bucello M, Kolb C, Frohman E. Efficacy of natalizumab extended dosing in multiple sclerosis: a retrospective multicenter analysis. Poster presentation at the joint ACTRIMS/ECTRIMS meeting 2014.
  22. Herbert J, Zhovtis Ryerson L, Tornatore C, Foley J, Weinstock-Guttman B, Kister I, Pandey K, Hojnacki D, Remington G, Frohman T, Major E, Douek D, Qureshi S, Beh S, Okuda D, Utomo P, Hoyt T , Chamot E, Bucello M, Ahsan I, Kolb C, Frohman E. Establishment of a global registry for multiple sclerosis patients on extended dose natalizumab schedules. Poster presentation at the joint ACTRIMS/ECTRIMS meeting 2014.
  23. Nolan R, Kannan N, Beh SC, Galetta SL. The utility of optical coherence tomography in acute monocular visual loss: is it optic nerve or retina? Poster presentation at the joint ACTRIMS/ECTRIMS meeting 2014.
  24. Beh SC, Conger D, Conger A, Sobhanian M, Calabresi PA, Balcer LJ, White O, Frohman T, Frohman EM.The Optic Nerve Head Component waveforns: characteristics in normal humans and disruption in multiple sclerosis. Poster presentation at the European Charcot Foundation 2014 Annual Meeting.
  25. Sobhanian MJ, Agarwal R, Conger D, Conger A, Calabresi P, Balcer LJ, Rennaker R, Beh SC, White O, Kardon R, Frohman T, Frohman EM. The Pulfrich phenomenon: an objective signature biomarker of MS pathophysiology. Poster presentation at the European Charcot Foundation 2014 Annual Meeting.
  26. Lucero M, Conger A, Conger D, Sobhanian M, Stokes V, Frohman TC, White O, Balcer LJ, Calabresi PA, Rennaker R, Frohman EM, Beh SCRetinal vessel oximetry and vessel diameter measurements: a novel metabolic marker of multiple sclerosis. Poster presentation at the North American Neuro-Ophthalmology (NANOS) 2015 Annual Meeting.
  27. Sobhanian MJ, Agarwal R, Conger D, Conger A, Balcer LJ, Rennaker R, Beh SC, White O, Kardon R, Frohman T, Frohman EM. The Pulfrich phenomenon: an objective signature biomarker of MS visual system pathophysiology. Poster presentation at the North American Neuro-Ophthalmology (NANOS) 2015 Annual Meeting.
  28. Lucero M, Conger A, Conger D, Sobhanian M, Stokes V, Frohman TC, White O, Balcer LJ, Calabresi PA, Rennaker R, Frohman EM, Beh SCRetinal Oximetry-Derived Biomarkers of Metabolic Dysfunction in MS. Poster presentation at the American Academy of Neurology (AAN) 2015 Annual Meeting.
  29. Sobhanian MJ, Agarwal, R, Conger D, Conger A, Calabresi P, Balcer LJ, Rennaker R, Beh SC, White O, Kardon R, Frohman T, Frohman EM. The Pulfrich phenomenon: an objective signature-biomarker of MS pathophysiology. Poster presentation at the American Academy of Neurology (AAN) 2015 Annual Meeting.
  30. Agarwal R, Sobhanian MJ, CongerD, CongerA, BalcerLJ, WhiteO, FrohmanT, OoiJ, BehSC, RennakerRL, Frohman EM. The Pulfrich Phenomenon: a signature of visual system pathophysiology in multiple sclerosis. Poster presentation at the ECTRIMS 2015 Annual Congress.
  31. Beh SC, Remington G,  Qureshi S, Hardeman P, Naryannan R, Frohman TC, Greenberg B, Frohman EM. High-dose intravenous methotrexate (HDMTX) with leucovorin rescue (LR) for the treatment of acute inflammatory demyelinating central nervous system (CNS) syndromes. Poster presentation at the ECTRIMS 2015 Annual Congress.
  32. Beh SC, Lucero M, Conger A, Conger D, Stokes V, Frohman TC, Calabresi PA, Rennaker RL 2nd, Balcer LJ, Frohman EM. Retinal Oximetry: A Novel Visual Biomarker of Retinal Metabolic Dysfunction in MS. Poster presentation at the ECTRIMS 2015 Annual Congress.
  33. Kildebeck EJ, Beh S, Sguigna P, Meltzer E, Balcer LJ, Calabresi P, Saidha S, Kardon R, Rennaker R, Frohman EM, Frohman TC. Blue light induced pupillary constriction reflexes: innovative identification of surrogate signatures for melanopsin-mediated signaling within the retinohypothalamic apparatus in human homeostasis and in neurodegenerative disorders. Poster presentation at the ECTRIMS 2016 Annual Congress.
  34. Narayanan RN, Beh SC, Kildebeck E, Desena A, Schell D, Rowe ES, Rowe V, Burns D, Whitworth L, Frohman TC, Greenberg B, Frohman EM. Treatment of refractory tumefactive multiple sclerosis with high-dose IV methotrexate with leucovorin rescue. Poster presentation at the ECTRIMS 2016 Annual Congress.
  35. Smith S, Friedman D, Beh SResolution of downbeat nystagmus following treatment with topiramate in a patient with vestibular migraine. Poster presentation at the North American Neuro-Ophthalmology Society (NANOS) 2017 Annual Meeting.
  36. Smith S, Masrour S, Friedman D, Beh SCharacterizing ocular motor abnormalities in patients with vestibular migraines and their response to migraine preventive therapy. Poster presentation at the American Academy of Neurology (AAN) 2017 Annual Meeting.
  37. Smith S, Beh SCImprovement of interictal ocular motor abnormalities in vestibular migraine following migraine preventive therapy. Poster presentation at the North American Neuro-Ophthalmology Society (NANOS) 2018 Annual Meeting.
  38. Beh SC, Masrour S, Smith SV, Friedman DI. Vestibular Migraine: Symptoms, Triggers, Exam Findings & Co-Morbid Disorders. Platform presentation at the American Academy of Neurology (AAN) 2019 meeting.
  39. Beh SC. Non-invasive vagus nerve stimulation as a rescue treatment for vestibular migraine. Poster presentation for the American Headache Society 61st Annual Scientific Meeting 2019